Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Qiagen NV acquires Enzyme Solutions unit of Enzymatics

Executive Summary

Qiagen NV acquired the Enzyme Solutions unit of Enzymatics Inc. for $114.2mm in cash (manufactures enzymes for next-generation sequencing (NGS)). The deal is expected to add approximately $20mm in incremental net sales to Qiagen in 2015, will be accretive to diluted EPS, and will allow the company to offer a complete NGS workflow.

Deal Industry
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition

Related Companies

UsernamePublicRestriction

Register